ArticleJournal of Cancer2019

Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancer.

Weiqi Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.